Nyssa Fox Farrell, MD

Nyssa Fox Farrell, MD

Assistant Professor of Otolaryngology—Head & Neck Surgery

Jill B. Firszt, PhD

Jill B. Firszt, PhD

Professor
Otolaryngology—Head and Neck Surgery
Director, Cochlear Implant Program

Dr. Firszt's clinical and research interests include bilateral and unilateral cochlear implants in adults and children, asymmetric hearing and unilateral haring loss, speech recognition, behavioral and electrophysiologic measures with electrical stimulation and optimization of speech processor mapping.

Heather Grantham, PhD

Heather Grantham, PhD

Associate Professor of Otolaryngology — Head and Neck Surgery

R. Alex Harbison, MD, MS

R. Alex Harbison, MD, MS

Assistant Professor of Otolaryngology—Head & Neck Surgery

Castle Connolly Top Doctor

Jacques A. Herzog, MD

Jacques A. Herzog, MD

Professor of Otolaryngology—Head & Neck Surgery;
Chief, Division of Otology/Neurotology

Castle Connolly Top Doctor

Keiko Hirose, MD

Keiko Hirose, MD

Professor of Otolaryngology—Head & Neck Surgery

Castle Connolly Top Doctor

Dr. Hirose's clinical interests include pediatric hearing loss, cochlear implantation, chronic ear surgery, cholesteatoma, conductive hearing loss, aural atresia, BAHA, ear infections, speech disorders, velopharyngeal insufficiency, cleft palate, craniofacial disorders.

Molly N. Huston, MD

Molly N. Huston, MD

Assistant Professor of Otolaryngology—Head & Neck Surgery

Division Chief, Laryngology

Ryan S.  Jackson, MD

Ryan S. Jackson, MD

Associate Professor of Otolaryngology—Head & Neck Surgery

Dorina Kallogjeri, MD, MPH

Dorina Kallogjeri, MD, MPH

Assistant Professor
Otolaryngology—Head & Neck Surgery

Jinkyung Kim, PhD

Jinkyung Kim, PhD

Assistant Professor of Otolaryngology—Head & Neck Surgery

The goal of the Kim Lab is to characterize the properties of sound coding and processing in the cochlea and along the auditory pathway through in vivo real-time monitoring of sound-evoked multicellular activities. Additionally, we aim to identify the transport mechanisms responsible for ototoxic drug entry into the cochlea via in vivo drug tracking and subsequently develop pathway blockers to prevent drug-induced hearing loss.